Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Rigel Pharmaceuticals
Rigel Pharmaceuticals
Centre Oscar Lambret
AstraZeneca
Cancer Research UK
Cancer Research UK
Institut du Cancer de Montpellier - Val d'Aurelle
University Health Network, Toronto